Join the club for FREE to access the whole archive and other member benefits.

Anastrozole gives long lasting protection against breast cancer

High-risk, post-menopausal women should ask their doctor about Anastrozole


Key points from article :

Anastrozole is given as an adjuvant therapy for postmenopausal women after breast cancer surgery.

It works by stopping peripheral production of estrogen after menopause.

Reduced the risk of recurrence of breast cancer by 50% during the five years women took the drug.

49% fewer breast cancers, even seven years after stopping anastrozole, so the benefits lasted.

Analysed trial results of 3,864 women treated for breast cancers.

Collaborative research by multiple institutes, published in the Lancet.

Mentioned in this article:

Click on resource name for more details.

Ivana Sestak

Expert in breast cancer epidemiology

Jack Cuzick

Professor and research scientist with an interest in cancer prevention

The Lancet

Medical journal covering general medicine

Topics mentioned on this page: